Vanda Stock Soars Over 15% As Cycle Pharma Reaffirms Buyout Deal: Bullish Retail Wants More

Barchart · 10/15 06:34
“In short, it is clear that Vanda’s Board is not acting in the best interests of shareholders,” Cycle said in a statement.